Clinical Trial Update: Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease

View source ↗

Summary

Eltrombopag was studied for efficacy and safety in patients with refractory thrombocytopenia associated with connective tissue diseases; the trial has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Diseases
• Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Tongji Hospital | Conditions: Refractory Thrombocytopenia, Connective Tissue Diseases | Status: COMPLETED